Roles of p38 MAPKs in invasion and metastasis

Biochemical Society Transactions

Volumn 40, Issue 1, 2012, Pages 79-84

  Barrantes, Ivan Del Barco ^a   Nebreda, Angel R ^a,b  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Cancer; Metastasis; p38 mitogen activated protein kinase (p38 MAPK); Tumour cell

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38;

ANOIKIS; CANCER INVASION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

ANIMALS; ANOIKIS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES;

EID: 84856243776     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20110676     Document Type: Review

References (60)

1. Nguyen, D.X., Bos, P.D. and Massague, J. (2009) Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274-284
2. Thiery, J.P., Acloque, H., Huang, R.Y. and Nieto, M.A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890
3. Aguirre-Ghiso, J.A. (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834-846
4. Joyce, J.A. and Pollard, J.W. (2009) Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252
5. Cuadrado, A. and Nebreda, A.R. (2010) Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417
6. Bulavin, D.V. and Fornace, Jr, A.J. (2004) p38 MAP kinase's emerging role as a tumor suppressor. Adv. Cancer Res. 92, 95-118 (Pubitemid 39458114)
7. Wagner, E.F. and Nebreda, A.R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549
8. Hong, J., Zhou, J., Fu, J., He, T., Qin, J., Wang, L., Liao, L. and Xu, J. (2011) Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 71, 3980-3990
9. Hipp, S., Berg, D., Ergin, B., Schuster, T., Hapfelmeier, A., Walch, A., Avril, S., Schmalfeldt, B., Hofler, H. and Becker, K.F. (2010) Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients. Virchows Arch. 457, 705-713
10. Zohn, I.E., Li, Y., Skolnik, E.Y., Anderson, K.V., Han, J. and Niswander, L. (2006) p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell 125, 957-969 (Pubitemid 43810156)
11. Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A. and Nebreda, A.R. (2007) p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11, 191-205 (Pubitemid 46209847)
12. Radisky, D.C., Levy, D.D., Littlepage, L.E., Liu, H., Nelson, C.M., Fata, J.E., Leake, D., Godden, E.L., Albertson, D.G., Nieto, M.A. et al. (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-127 (Pubitemid 40966197)
13. Al-Mulla, F., Bitar, M.S., Al-Maghrebi, M., Behbehani, A.I., Al-Ali, W., Rath, O., Doyle, B., Tan, K.Y., Pitt, A. and Kolch, W. (2011) Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β. Cancer Res. 71, 1334-1343
14. Parvani, J.G., Taylor, M.A. and Schiemann, W.P. (2011) Noncanonical TGF-β signaling during mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia 16, 127-146
15. Sorrentino, A., Thakur, N., Grimsby, S., Marcusson, A., von Bulow, V., Schuster, N., Zhang, S., Heldin, C.H. and Landstrom, M. (2008) The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat. Cell Biol. 10, 1199-1207
16. Yamashita, M., Fatyol, K., Jin, C., Wang, X., Liu, Z. and Zhang, Y.E. (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol. Cell 31, 918-924
17. Taylor, M.A., Amin, J.D., Kirschmann, D.A. and Schiemann, W.P. (2011) Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells. Neoplasia 13, 406-418
18. Sullivan, N.J., Sasser, A.K., Axel, A.E., Vesuna, F., Raman, V., Ramirez, N., Oberyszyn, T.M. and Hall, B.M. (2009) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28, 2940-2947
19. Lyons, J.G., Patel, V., Roue, N.C., Fok, S.Y., Soon, L.L., Halliday, G.M. and Gutkind, J.S. (2008) Snail up-regulates proinflammatory mediators and inhibits differentiation in oral keratinocytes. Cancer Res. 68, 4525-4530
20. Kumar, S., Boehm, J. and Lee, J.C. (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discovery 2, 717-726 (Pubitemid 37361787)
21. Zauberman, A., Zipori, D., Krupsky, M. and Ben-Levy, R. (1999) Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3. Oncogene 18, 3886-3893 (Pubitemid 29358567)
22. Emerling, B.M., Platanias, L.C., Black, E., Nebreda, A.R., Davis, R.J. and Chandel, N.S. (2005) Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol. Cell. Biol. 25, 4853-4862 (Pubitemid 40781087)
23. Lopez-Novoa, J.M. and Nieto, M.A. (2009) Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol. Med. 1, 303-314
24. Strippoli, R., Benedicto, I., Foronda, M., Perez-Lozano, M.L., Sánchez-Perales, S., López-Cabrera, M. and Del Pozo, M.Á. (2010) p38 maintains E-cadherin expression by modulating TAK1-NF-κB during epithelial-to-mesenchymal transition. J. Cell Sci. 123, 4321-4331
25. Laferriere, J., Houle, F., Taher, M.M., Valerie, K. and Huot, J. (2001) Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J. Biol. Chem. 276, 33762-33772
26. Rousseau, S., Dolado, I., Beardmore, V., Shpiro, N., Marquez, R., Nebreda, A.R., Arthur, J.S., Case, L.M., Tessier-Lavigne, M., Gaestel, M. et al. (2006) CXCL12 and C5a trigger cell migration via a PAK1/2-p38αMAPK- MAPKAP-K2-HSP27 pathway. Cell. Signalling 18, 1897-1905 (Pubitemid 44485980)
27. Kobayashi, M., Nishita, M., Mishima, T., Ohashi, K. and Mizuno, K. (2006) MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J. 25, 713-726 (Pubitemid 43292434)
28. Coussens, L.M., Fingleton, B. and Matrisian, L.M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392 (Pubitemid 34270240)
29. Hsieh, M.J., Chen, K.S., Chiou, H.L. and Hsieh, Y.S. (2010) Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. Eur. J. Cell Biol. 89, 598-606
30. Johansson, N., Ala-aho, R., Uitto, V., Grénman, R., Fusenig, N.E., López-Otín, C. and Kähäri, V.M. (2000) Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J. Cell Sci. 113, 227-235 (Pubitemid 30088968)
31. Kumar, P., Yadav, A., Patel, S.N., Islam, M., Pan, Q., Merajver, S.D. and Teknos, T.N. (2010) Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis. Mol. Cancer 9, 206
32. Park, S.Y., Jeong, K.J., Panupinthu, N., Yu, S., Lee, J., Han, J.W., Kim, J.M., Lee, J.S., Kang, J., Park, C.G. et al. (2011) Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene 30, 1351-1359
33. Xu, L., Chen, S. and Bergan, R.C. (2006) MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 25, 2987-2998 (Pubitemid 43780463)
34. Villares, G.J., Zigler, M., Dobroff, A.S., Wang, H., Song, R., Melnikova, V.O., Huang, L., Braeuer, R.R. and Bar-Eli, M. (2011) Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proc. Natl. Acad. Sci. U.S.A. 108, 626-631
35. Huang, S., New, L., Pan, Z., Han, J. and Nemerow, G.R. (2000) Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38αmitogen- activated protein kinase activity. J. Biol. Chem. 275, 12266-12272 (Pubitemid 30237807)
36. Blasi, F. and Carmeliet, P. (2002) uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3, 932-943 (Pubitemid 35477371)
37. Ho, J.N., Lee, S.B., Lee, S.S., Yoon, S.H., Kang, G.Y., Hwang, S.G. and Um, H.D. (2010) Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells. Mol. Cancer Ther. 9, 825-832
38. Wang, R., Li, Z.Q., Han, X., Li, B.L., Mi, X.Y., Sun, L.M., Song, M., Han, Y.C., Zhao, Y. and Wang, E.H. (2010) Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer. APMIS 118, 909-917
39. Dreissigacker, U., Mueller, M.S., Unger, M., Siegert, P., Genze, F., Gierschik, P. and Giehl, K. (2006) Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. Cell. Signalling 18, 1156-1168 (Pubitemid 43674042)
40. Hsieh, Y.H., Wu, T.T., Huang, C.Y., Hsieh, Y.S., Hwang, J.M. and Liu, J.Y. (2007) p38 mitogen-activated protein kinase pathway is involved in protein kinase Cα-regulated invasion in human hepatocellular carcinoma cells. Cancer Res. 67, 4320-4327
41. Junttila, M.R., Ala-Aho, R., Jokilehto, T., Peltonen, J., Kallajoki, M., Grenman, R., Jaakkola, P., Westermarck, J. and Kahari, V.M. (2007) p38αand p38δ mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells. Oncogene 26, 5267-5279 (Pubitemid 47237627)
42. Demuth, T., Reavie, L.B., Rennert, J.L., Nakada, M., Nakada, S., Hoelzinger, D.B., Beaudry, C.E., Henrichs, A.N., Anderson, E.M. and Berens, M.E. (2007) MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival. Mol. Cancer Ther. 6, 1212-1222 (Pubitemid 46711984)
43. Behren, A., Muhlen, S., Acuna Sanhueza, G.A., Schwager, C., Plinkert, P.K., Huber, P.E., Abdollahi, A. and Simon, C. (2010) Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion. Oncogene 29, 1519-1530
44. Loesch, M., Zhi, H.Y., Hou, S.W., Qi, X.M., Li, R.S., Basir, Z., Iftner, T., Cuenda, A. and Chen, G. (2010) p38γ MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J. Biol. Chem. 285, 15149-15158
45. Meng, F., Zhang, H., Liu, G., Kreike, B., Chen, W., Sethi, S., Miller, F.R. and Wu, G. (2011) p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)- polymerase-1 inhibition in breast cancer. Neoplasia 13, 472-482
46. Hickson, J.A., Huo, D., Vander Griend, D.J., Lin, A., Rinker-Schaeffer, C.W. and Yamada, S.D. (2006) The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res. 66, 2264-2270
47. 2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res. 65, 10984-10991
48. Lagadec, C., Meignan, S., Adriaenssens, E., Foveau, B., Vanhecke, E., Romon, R., Toillon, R.A., Oxombre, B., Hondermarck, H. and Le Bourhis, X. (2009) TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene 28, 1960-1970
49. Owens, T.W., Valentijn, A.J., Upton, J.P., Keeble, J., Zhang, L., Lindsay, J., Zouq, N.K. and Gilmore, A.P. (2009) Apoptosis commitment and activation of mitochondrial Bax during anoikis is regulated by p38 MAPK. Cell Death Differ. 16, 1551-1562
50. Zhang, Y., Rivera Rosado, L.A., Moon, S.Y. and Zhang, B. (2009) Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling. J. Biol. Chem. 284, 12956-12965
51. Wen, H.-C., Avivar-Valderas, A., Sosa, M.S., Girnius, N., Farias, E.F., Davis, R.J. and Aguirre-Ghiso, J.A. (2011) p38α signaling induces anoikis and lumen formation during mammary morphogenesis. Sci. Signal. 4, ra34
52. Tremblay, P.L., Auger, F.A. and Huot, J. (2006) Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 25, 6563-6573 (Pubitemid 44646184)
53. Matsuo, Y., Amano, S., Furuya, M., Namiki, K., Sakurai, K., Nishiyama, M., Sudo, T., Tatsumi, K., Kuriyama, T., Kimura, S. and Kasuya, Y. (2006) Involvement of p38α mitogen-activated protein kinase in lung metastasis of tumor cells. J. Biol. Chem. 281, 36767-36775 (Pubitemid 46042144)
54. Roussel, L., Houle, F., Chan, C., Yao, Y., Berube, J., Olivenstein, R., Martin, J.G., Huot, J., Hamid, Q., Ferri, L. and Rousseau, S. (2010) IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J. Immunol. 184, 4531-4537
55. Hiratsuka, S., Watanabe, A., Aburatani, H. and Maru, Y. (2006) Tumourmediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375 (Pubitemid 44835111)
56. Hiratsuka, S., Duda, D.G., Huang, Y., Goel, S., Sugiyama, T., Nagasawa, T., Fukumura, D. and Jain, R.K. (2011) C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells. Proc. Natl. Acad. Sci. U.S.A. 108, 302-307
57. Rousseau, S., Houle, F. and Huot, J. (2000) Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Trends Cardiovasc. Med. 10, 321-327 (Pubitemid 32448042)
58. McMullen, M.E., Bryant, P.W., Glembotski, C.C., Vincent, P.A. and Pumiglia, K.M. (2005) Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J. Biol. Chem. 280, 20995-21003 (Pubitemid 40805657)
59. Erler, J.T., Bennewith, K.L., Cox, T.R., Lang, G., Bird, D., Koong, A., Le, Q.T. and Giaccia, A.J. (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44
60. SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res. 69, 5664-5672